CORINDUS VASCULAR ROBOTICS, INC. (NYSEMKT:CVRS) Files An 8-K Other Events

Item 8.01. Other Events.

On February 28, 2017, Corindus Vascular Robotics, Inc. (the
Company) issued a press release entitled Corindus Vascular
Robotics Announces Private Placement for $45 Million, announcing
the execution of a Securities Purchase Agreement to which it will
issue and sell an aggregate of 67,941,346 shares of its common
stock in a private placement at a purchase price of $0.6616 per
share, resulting in aggregate gross proceeds to the Company of
approximately $45,000,000. A copy of the press release is
attached hereto as Exhibit 99.1 and is incorporated herein by
reference.

Item 9.01.Financial Statements and Exhibits.

(d)Exhibits.

About CORINDUS VASCULAR ROBOTICS, INC. (NYSEMKT:CVRS)

Corindus Vascular Robotics, Inc. designs, manufactures and sells precision vascular robotic-assisted systems for use in interventional vascular procedures (the CorPath System). The Company operates through the development, marketing and sales of robotic-assisted vascular interventions segment. The Company’s product, the CorPath 200 System, is a vascular robotic system, which is engaged in stent placement in percutaneous coronary intervention (PCI) procedures. The CorPath System enables the robotic-assisted control of coronary guidewires and balloon/stent devices from the safety of a radiation-protected, ergonomic interventional cockpit. The CorPath System consists of two components: a bedside unit and an interventional cockpit. At the bedside, the CorPath System’s robotic drive and sterile, single-use cassette (CorPath Cassette) translate the physician’s commands into movements and manipulations of the coronary stents and catheters.

CORINDUS VASCULAR ROBOTICS, INC. (NYSEMKT:CVRS) Recent Trading Information

CORINDUS VASCULAR ROBOTICS, INC. (NYSEMKT:CVRS) closed its last trading session up +0.031 at 0.662 with 411,180 shares trading hands.